Patents by Inventor Somayeh Pouyanfard

Somayeh Pouyanfard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • L2 peptide immunogenicity
    Patent number: 10736954
    Abstract: The present invention relates to an immunogenic polypeptide comprising a multitude of human papillomavirus (HPV) L2 N-terminal peptides corresponding to amino acids 20 to 50 of the L2 polypeptide of HPV16, wherein said HPV L2 N-terminal peptides are L2 N-terminal peptides from at least two different HPV genotypes. The present invention also relates to said immunogenic polypeptide for use in medicine and for use in vaccination against HPV infection. Moreover, the present invention relates to a polynucleotide encoding the immunogenic polypeptide and to a host cell comprising the same. Moreover, the present invention relates to kits, methods, and uses related to the immunogenic polypeptide of the invention.
    Type: Grant
    Filed: June 7, 2017
    Date of Patent: August 11, 2020
    Assignee: Deutsches Krebsforschungzentrum
    Inventors: Angelo Bolchi, Martin Müller, Simone Ottonello, Somayeh Pouyanfard, Gloria Spagnoli
  • Improvement of L2 Peptide Immunogenicity
    Publication number: 20190125856
    Abstract: The present invention relates to an immunogenic polypeptide comprising a multitude of human papillomavirus (HPV) L2 N-terminal peptides corresponding to amino acids 20 to 50 of the L2 polypeptide of HPV16, wherein said HPV L2 N-terminal peptides are L2 N-terminal peptides from at least two different HPV genotypes. The present invention also relates to said immunogenic polypeptide for use in medicine and for use in vaccination against HPV infection. Moreover, the present invention relates to a polynucleotide encoding the immunogenic polypeptide and to a host cell comprising the same. Moreover, the present invention relates to kits, methods, and uses related to the immunogenic polypeptide of the invention.
    Type: Application
    Filed: June 7, 2017
    Publication date: May 2, 2019
    Inventors: Angelo Bolchi, Martin Müller, Simone Ottonello, Somayeh Pouyanfard, Gloria Spagnoli